<DOC>
	<DOC>NCT01649687</DOC>
	<brief_summary>The study is to investigate the efficacy and safety of allogenous transplantation of adipose-derived mesenchyma stem cells in patients with cerebellar ataxia.</brief_summary>
	<brief_title>Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells</brief_title>
	<detailed_description />
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<criteria>Patients diagnosed of spinocerebellar ataxia 3 (SCA3) or multiple system atrophycerebellar (MSAC). Subject's SARA score at 10~20 points. Ages between 20~70 years. Signed informed consent from the patient and/or guardian. Subjects enrolled in any other cell therapy studies within the past 30 days. Pregnancy test positive. Subjects deemed to be not suitable for the study by the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>